Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
303.00
339.00
304.00
281.00
250.00
171.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
303.00
339.00
304.00
281.00
250.00
171.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-1.00
-17.00
-4.00
5.00
3.00
Raw Materials Consumed
164.00
192.00
190.00
172.00
145.00
81.00
Power & Fuel Cost
8.00
8.00
7.00
5.00
4.00
4.00
Employee Cost
62.00
60.00
55.00
47.00
41.00
50.00
Operating Expenses
10.00
13.00
13.00
10.00
8.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
12.00
9.00
12.00
12.00
8.00
8.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
1.00
2.00
3.00
3.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
273.00
308.00
278.00
257.00
225.00
166.00
Operating Profit (PBDIT) excl Other Income
29.00
30.00
25.00
23.00
24.00
5.00
Other Income
2.00
2.00
0.00
5.00
1.00
1.00
Operating Profit (PBDIT)
31.00
33.00
26.00
28.00
25.00
6.00
Interest
17.00
14.00
12.00
10.00
12.00
12.00
Profit before Depriciation and Tax
14.00
19.00
13.00
18.00
13.00
-5.00
Depreciation
9.00
10.00
9.00
9.00
9.00
7.00
Profit Before Taxation & Exceptional Items
5.00
9.00
4.00
9.00
4.00
-13.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
5.00
9.00
4.00
9.00
4.00
-13.00
Provision for Tax
-2.00
1.00
2.00
3.00
0.00
0.00
Profit After Tax
7.00
7.00
2.00
5.00
4.00
-12.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
22.00
14.00
13.00
9.00
12.00
26.00
Profit Available for appropriations
29.00
22.00
16.00
15.00
17.00
14.00
Appropriations
29.00
22.00
16.00
15.00
17.00
14.00
Equity Dividend (%)
12.00%
12.00%
10.00%
10.00%
10.00%
0.00%
Earnings Per Share
4.54
4.96
1.67
3.79
3.34
-8.62
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -10.65% vs 11.51% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -3.80% vs 22.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 16.29% vs 19.10% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -2.81% vs 184.26% in Mar 2024
Compare Profit and Loss Results of Bal Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
303.00
0
303.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
303.00
0
303.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0
-7.00
0%
Raw Materials Consumed
164.00
0
164.00
0%
Power & Fuel Cost
8.00
0
8.00
0%
Employee Cost
62.00
0
62.00
0%
Operating Expenses
10.00
0
10.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
12.00
0
12.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
273.00
0
273.00
0%
Operating Profit (PBDIT) excl Other Income
29.00
0.00
29.00
0%
Other Income
2.00
0
2.00
0%
Operating Profit (PBDIT)
31.00
0
31.00
0%
Interest
17.00
0
17.00
0%
Profit before Depriciation and Tax
14.00
0
14.00
0%
Depreciation
9.00
0
9.00
0%
Profit Before Taxation & Exceptional Items
5.00
0
5.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
5.00
0
5.00
0%
Provision for Tax
-2.00
0
-2.00
0%
Profit After Tax
7.00
0
7.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
22.00
0
22.00
0%
Profit Available for appropriations
29.00
0
29.00
0%
Appropriations
29.00
0
29.00
0%
Equity Dividend (%)
12%
0%
12.00
Earnings Per Share
4.54
0
4.54
0%
Profit And Loss - Net Sales
Net Sales 303.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -10.65% vs 11.51% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.76 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.80% vs 22.52% in Mar 2024
Profit And Loss - Interest
Interest 17.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.29% vs 19.10% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 7.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.81% vs 184.26% in Mar 2024






